Increased serum trypsinogen 2 and trypsin 2-α1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy

Gut

Volumn 41, Issue 5, 1997, Pages 690-695

  Kemppainen, E ^a   Hedstrom J ^a   Puolakkainen, P ^a   Halttunen, J ^a   Sainio, V ^a   Haapiainen, R ^a   Kivilaakso, E ^a   Stenman, U H ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Antitrypsin complex; ERCP; Pancreatitis; Trypsin 2 ; Trypsinogen 2

Indexed keywords

ALPHA 1 ANTITRYPSIN; AMYLASE; TRYPSIN; TRYPSINOGEN;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030695992     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.5.690     Document Type: Article

References (25)

1. Bilbao MK, Dotter CT, Lee TG, Caton RM. Complications of endoscopic retrograde cholangiopancreaticography: a study of 10 000 cases. Gastroentrology 1976; 70: 314-20.
2. Sherman S, Lehman GA. ERCP- and endoscopic sphincterotomy-induced pancreatitis. Pancreas 1991; 6: 350-67.
3. Vandervoort J, Carr-Locke DL. Needle-knife papillotomy: an unfairly maligned technique. Endoscopy 1996; 28: 365-6.
4. Conn M, Goldenberger A, Concepcion L, Mandeli J. The effect of ERCP on circulating pancreatic enzymes and pancreatic protease inhibitors. Am J Gastroenterol 1991; 86: 1011-4.
5. Skude G, Wehlin L, Maruyama T, Ariyama J. Hyperamylasaemia after duodenoscopy and retrograde cholangiopancreaticography. Gut 1976; 17: 127-32.
6. Stanten R, Frey C. Pancreatitis after endoscopic retrograde cholangiopancreaticography: an underreported disease whose severity is often unappreciated. Arch Surg 1990; 125: 1032-5.
7. Sternlieb J, Aronchick C, Retig J, Dabezies M, Saunders F, Goosenberg E, et al. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Am J Gastroenterol 1992: 11: 1561-6.
8. 1-antitrypsin deficiency. Lancet 1988; ii: 772.
9. Hamilton I, Lintott DJ, Rothwell J, Axon ATR. Acute pancreatitis following endoscopie retrograde cholangiopancreaticography. Clin Radial 1983; 34: 543-6.
10. Johnson GK, Geenen JE, Bedford RA, Johanson J, Cass O, Sherman S, et al. A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Gastrointest Endosc 1995; 42: 312-6.
11. Thornton J, Axon A. Towards safer endoscopie retrograde cholangiography. Gut 1993; 34: 721-4.
12. Chen YK, Foliente RLF, Santoro MJ, Walter MH, Collen MJ. Endoscopie sphincterotomy-induced pancreatitis: increased risk associated with nondilatated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol 1994; 89: 327-33.
13. Freeman M, Nelson D, Sherman S, Herman M, Haber G, Moore J, et al. Pancreatitis from endoscopy sphincterotomy (ES): a prospective, multicenter, 30-day study [abstract]. Gastrointest Endosc 1994; 40: P20.
14. Borgström A, Wehlin L, Correlation between serum concentrations of three specific exocrine pancreatic proteins and pancreatic duct morphology at ERCP examinations. Scand J Gastroenterol 1984; 19: 220-7.
15. Cotton PB, Lehman G, Vennes J. Endoscopie sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1992; 37: 383-93.
16. Ohlsson K, Eddeland A. Release of proteolytic enzymes in bile-induced pancreatitis in dogs. Gastroenterology 1975; 69: 668-75.
17. Borgström A, Ohlsson K. Studies on the turnover of endogenous cathodal trypsinogen in man. Eur J Clin Invest 1978; 8: 379-82.
18. Itkonen O, Koivunen E, Hurme M, Alftan H, Schröder T, Stenman UH. Time-resolved immunofluorometric assay for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 1990; 115: 712-8.
19. Hedström J, Sainio V, Kemppainen E, Haapiainen R, Kivilaakso E, Schröder T, et al. Serum complex of trypsin-2 and alpha-1-antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients. BMJ 1996; 313: 333-7.
20. Hedström J, Leinonen J, Sainio V, Stenman U-H. Time resolved immunofluorometric assay of trypsinogen-2 complexed with alpha-1-antitrypsin in serum. Clin Chem 1994; 40: 1761-5.
21. Sainio V, Puolakkainen P, Kemppainen E, Hedström J, Haapiainen R, Kivisaari L, et al. Serum trypsinogen-2 in the prediction of outcome in acute necrotizing pancreatitis. Scand J Gastroenterol 1996; 31: 818-24.
22. 1 antitrypsin complex in malignant and benign digestive tract diseases. Preferential elevation in patients with cholangiocarcinomas. Int J Cancer 1996; 66: 326-31.
23. Hjelmqvist B, Wattsgård C, Borgström Å, Lasson Å, Nyman U, Ohlsson K. Pathobiochemistry and early CT findings in acute pancreatitis. Digestion 1989; 44: 184-90.
24. Lasson Å, Ohlsson K. Protease inhibitors in acute pancreatitis. Correlation between biochemical changes and clinical course. Scand J Gastroenterol 1984; 19: 779-86.
25. Sainio V, Kemppainen E, Puolakkainen P, Taavitsainen M, Kivisaari L, Valtonen V, et al. Early antibiotic treatment in acute necrotizing pancreatitis. Lancet 1995; 346: 663-7.